Frontlight ResearchEarly access
Trial site
Szpital Specjalistyczny Nr I W Bytomiu SPZOZ
- 6running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)4 trials
- Systemic sclerosis (scleroderma)3 trials
- Childhood cancers1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Giant cell arteritis1 trial
- Hepatitis B1 trial
- Polymyalgia rheumatica1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
- Celgene1 trial
- Celgene Corp.1 trial
- GlaxoSmithKline1 trial
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Recruiting
Active, not recruiting
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)2 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
- Childhood cancers1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026